Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.
Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...
As climate conditions become increasingly unpredictable, understanding how plants respond to cold is crucial for securing ...
The lab of Dan Xu, PhD, assistant professor at The Hormel Institute, has published a groundbreaking study in Cell Metabolism, ...
This is the moment a gang posing as a legitimate company blew up a cable as they tried to splice electricity into an Albanian ...
Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through ...
Tyr Pharma (ATYR) announced a publication demonstrating the mechanism of action for its lead therapeutic candidate, efzofitimod, in the ...
Ross McGinn ran the company Elev8 with Andrew Roberts, splicing electricity from the national grid to power a network of drug ...
12d
McGinn, 33 and of Midway Road in Huyton, was sentenced to five years and four months, while Andrew Roberts, 42 and of Bell ...
President Donald Trump’s nominee for FDA Commissioner, Martin A. Makary, MD, sought to assure senators that if confirmed, he would support efforts to expedite reviews of new drugs indicted for rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback